EP Patent

EP1248596A2 — Kit zur implantation enthaltend eine trägerphase und ein lösemittel

Assigned to bertex Pharma GmbH · Expires 2002-10-16 · 24y expired

What this patent protects

Patent listed against Risperdal.

Drugs covered by this patent

Patent Metadata

Patent number
EP1248596A2
Jurisdiction
EP
Classification
—
Expires
2002-10-16
Drug substance claim
No
Drug product claim
No
Assignee
bertex Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.